top of page

Congratulations, Philipp Heider!

Writer: Michael Zürcher
Michael Zürcher
13 hours ago
1 min read

We’re delighted to announce that Philipp Heider has been promoted to Market Entry and Access Director Switzerland at Swizzard Pharma AG, effective December 1, 2026.


Combining expertise in medical affairs, market access and digital innovation, Philipp brings a strong scientific background, strategic thinking and a hands-on approach to solving complex challenges. In his new role, he will continue to help our biotech and pharma clients navigate the Swiss market and bring innovative therapies to patients.


Congratulations on this next step, Philipp, and thank you for your valuable contribution to Swizzard and our clients!



About Swizzard

Swizzard Pharma AG supports biotech and pharma companies in successfully entering and thriving in the Swiss market. Committed to bringing innovation to Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs through expert market entry, preparation, commercialization and access strategies. With deep industry expertise, hands-on experience and an extensive network, Swizzard delivers fast, efficient, and tailored solutions. The company is led by CEO Michael Zürcher, a seasoned life sciences executive with a strong track record in the industry.




Comments


bottom of page